Biotechnology

AI & Genomics Advances Bring New Hope to Lung Cancer Burden in Asia

SINGAPORE, Feb. 5, 2025 /PRNewswire/ -- Asia is the region most impacted by lung cancer, accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1). Many countries have applied low-dose CT scans to screen for this deadly cancer to improve early detection an...

2025-02-05 14:00 5708

Aussie sleeptech firm unveils breakthrough test

MELBOURNE, Australia, Feb. 5, 2025 /PRNewswire/ -- Australian medical technology company Optalert has revealed a breakthrough test for sleep issues, expanding access to sleep health technologies for millions of Australians. The simple test is conducted within 10 minutes on a smartphone, making it...

2025-02-05 13:36 2611

NABR Applauds CITES Standing Committee's Decision Not to Enact Trade Suspension on Cambodia's Long-Tailed Macaques

WASHINGTON, Feb. 5, 2025 /PRNewswire/ -- The National Association for Biomedical Research (NABR) commends the CITES Standing Committee's decision not to enact a trade suspension on long-tailed macaques (Macaca fascicularis) from Cambodia. This decision underscores the international community's st...

2025-02-05 06:48 3267

Bayer Foundation Women Entrepreneurs Award: Applications Open for Innovators in Health and Food Security

LEVERKUSEN, Germany, Feb. 4, 2025 /PRNewswire/ -- Bayer Foundation, in partnership withImpact Hub Network, has opened applications  for the 2025 Women Entrepreneurs Award , offeri...

2025-02-04 16:01 4386

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics

TORONTO, Jan. 30, 2025 /PRNewswire/ -- Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical isotope will enable Isotopia's production of Terbium-161 (Tb-161), a medical isoto...

2025-01-30 12:00 3870

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

AAT announces additional significant updates RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. ("AAT") announced today that their partner inChina has obtained approval to market their unique dermal filler Algeness® VL agarose facial injection filler, a 2.5% agarose...

2025-01-29 14:00 3883

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-dr...

2025-01-28 22:07 3548

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyte™. The announcement coincide...

2025-01-28 00:00 3879

Seeking Investors: First-in-Class Immunotherapeutics for Cancer

ATLANTA, Jan. 27, 2025 /PRNewswire/ -- Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, and the company observes no toxicity-limiting dosages. In ...

2025-01-27 19:58 3514

Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai , and announced astrategic investment and partnership with Inogen, a leading U.S. company in respiratory health, highlighting our joint commitmen...

2025-01-27 11:25 4978

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 25, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infectio...

2025-01-25 02:00 6326

Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization inChina from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed innovativ...

2025-01-23 13:44 3591

GC Cell Symposium with Bifarma Expands Global Impact and Reach for Immuncell-LC

YONGIN, South Korea, Jan. 23, 2025 /PRNewswire/ -- GC Cell , a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized in collaboration with PT Bifarma Ad...

2025-01-23 09:30 2860

Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), GPC Bio, and Eleszto Genetika Announce Strategic Unification

NORTON, Va., LA ROCHELLE, France and BUDAPEST, Hungary, Jan. 23, 2025 /PRNewswire/ -- Today, SOLARBIOTECH, GPC Bio, and Eleszto Genetika proudly announced their acquisition and strategic unification under a single ownership.  This consolidation creates a vertically integrated Synthetic Biology an...

2025-01-23 05:53 3228

2025 Japan Prize Laureates Announced

TOKYO, Jan. 22, 2025 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2025 Japan prize onJanuary 22, 2025. Prof. Russell Dean Dupuis of theUSA has been awarded the Japan Prize in the fields of Materials Sciences and Production, and Prof.Carlos M. Duarte of Spain has been aw...

2025-01-22 15:00 1408

Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers

HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement withArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug conjugate ("ADC") for the treatment of Gastrointesti...

2025-01-22 12:19 4611

The BioCircular Materials Alliance initiated by Spiber welcomes new partners including Stella McCartney and publishes its first Progress Report

* Stella McCartney, Marzotto Wool Manufacturing Srl, Fashion for Good, and 13 new companies and organizations have joined the BioCircular Materials Alliance (the "Alliance"), led by biomaterials pioneer Spiber. * The Alliance published its first Progress Report, highlighting ongoing research ...

2025-01-21 18:00 4428

SIRPAD - WORLD'S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT

TAMPA, Fla., Jan. 20, 2025 /PRNewswire/ -- Concept Medical Inc . (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the successful completion of patient enrolment in the SirPAD Trial, with over 1,250 pat...

2025-01-20 21:44 4480

Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins

YICHANG, China, Jan. 17, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast manufacturing, has officially completed the topping out of the main plant for the industrial yeast protein production project at Baiyang Yichang, which will boost an annual ...

2025-01-17 22:46 11665

Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU, China, Jan. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metaboli...

2025-01-17 08:00 6054
1 ... 32333435363738 ... 186

Week's Top Stories